GlassScriptPhysician profile
Brittainy Legai Dark
NPI 1144535790
$2,239.92
in general payments reported to CMS, 2019-2025
21 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $191 · 2021: $302 · 2022: $144 · 2023: $296 · 2024: $130 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $634.44 | 2019-2025 | |
| Daiichi Sankyo INC. | $171.29 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $169.90 | 2022-2025 | |
| Abbvie INC. | $167.36 | 2020-2023 | Liletta |
| Coopersurgical, INC. | $150.43 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Baxter Healthcare | $143.62 | 2020-2025 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $122.62 | 2019-2024 | |
| Medtronic, INC. | $99.85 | 2022-2023 | |
| Therapeuticsmd, INC. | $93.83 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $81.34 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Hologic Sales and Service, LLC | $81.31 | 2019-2025 | Aptima, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Avion Pharmaceuticals | $79.78 | 2019-2021 | |
| Lupin INC. | $39.58 | 2019 | |
| Teleflex LLC | $35.93 | 2019 | |
| Organon LLC | $34.52 | 2022-2025 | Jada System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.34 | 2019 | |
| Becton, Dickinson and Company | $26.30 | 2025 | Arista |
| Aspira Women'S Health INC | $23.66 | 2024 | Ova1 |
| Biogen, INC. | $23.51 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $23.23 | 2019 | |
| Boston Scientific Corporation | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittainy Dark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.